M

MaxCyte
D

MXCT

3.39000
USD
-0.23
(-6.22%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-10
Market Cap
357,585,872
News

Title: MaxCyte

Sector: Healthcare
Industry: Medical Devices
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.